Company news
PomDoctor Ltd. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
POMDOCTOR LIMITED Announces the Termination of Its ADR Program and Trade Class A Ordinary Shares on Nasdaq
October 19, 2026
POMDOCTOR LIMITED Highlights the Shift from Reactive Treatment to Predictive Healthcare
October 12, 2026
POMDOCTOR LIMITED Announces Receipt of Nasdaq Staff Delisting Determination
October 9, 2026
POMDOCTOR LIMITED Accelerates AI-Enabled Chronic Disease Management and RWD Commercialization
September 30, 2026
POMDOCTOR LIMITED Highlights Differentiated "Hardware + AI + Payment" Healthcare Infrastructure Model
September 24, 2026
POMDOCTOR LIMITED to Participate in H.C. Wainwright's 28th Annual Global Investment Conference
September 10, 2026
POMDOCTOR LIMITED Initiates U.S. Market Preparation and Unveils Expansion Strategy
August 27, 2026
POMDOCTOR LIMITED Highlights Healthcare Intelligence Flywheel as a Self-Reinforcing Growth Engine
August 10, 2026
POMDOCTOR LIMITED Highlights Four-Tier Diversified Revenue Structure
August 3, 2026
POMDOCTOR LIMITED Regains Compliance with Nasdaq Bid Price Requirement
July 13, 2026
POMDOCTOR LIMITED Announces Strategic Upgrade Toward Infrastructure for Predictive Healthcare Data and Services
July 2, 2026
POMDOCTOR LIMITED Announces ADS Ratio Change to Be Effective on June 22, 2026
June 17, 2026
POMDOCTOR LIMITED Announces Plan to Implement ADS Ratio Change
May 28, 2026
POMDOCTOR LIMITED Announces Fiscal Year 2025 Financial Results
May 14, 2026
POMDOCTOR LIMITED Announces Strategic Upgrade, Focusing on "AI + Medical-Grade Smart Wearables" to Build a New Ecosystem for Full-Cycle Chronic Disease Management
March 13, 2026
POMDOCTOR LIMITED Announces Full Exercise and Closing of Underwriter's Over-Allotment Option
October 10, 2025
POMDOCTOR LIMITED Announces Closing of Initial Public Offering
October 9, 2025